QbD-enabled systematic development of gastroretentive multiple-unit microballoons of itopride hydrochloride

References

• Ahuja N, Katare OP, Singh B. (2007). Studies on dissolution enhancement and mathematical modeling of drug release of a poorly water-soluble drug using water-soluble carriers. Eur J Pharm Biopharm 65:26–38
   PubMed Web of Science ®Google Scholar
• Awasthi R, Kulkarni GT, Pawar VK, Garg G. (2012). Optimization studies on gastroretentive floating system using response surface methodology. AAPS PharmSciTech 13:85–93
   PubMed Web of Science ®Google Scholar
• Chawla A, Sharma P, Pawar P. (2012). Eudragit S-100 coated sodium alginate microspheres of naproxen sodium: formulation, optimization and in vitro evaluation. Acta Pharma 62:529–45
   PubMed Web of Science ®Google Scholar
• Costa P, Lobo JMS. (2001). Modeling and comparison of dissolution profiles. Eur J Pharm Sci 13:123–33
   PubMed Web of Science ®Google Scholar
• Fahmy R, Kona R, Dandu R, et al. (2012). Quality by design I: application of failure mode effect analysis (FMEA) and Plackett-Burman design of experiments in the identification of “main factors” in the formulation and process design space for roller-compacted ciprofloxacin hydrochloride immediate-release tablets. AAPS PharmSciTech 13:1243–54
   PubMed Web of Science ®Google Scholar
• Gupta H, Bhandari D, Sharma A. (2009). Recent trends in oral drug delivery: a review. Recent Pat Drug Deliv Formul 3:162–73
   PubMedGoogle Scholar
• Gupta KR, Joshi RR, Chawla RB, Wadodkar SG. (2010). UV-Spectrophotometric method for the estimation of itopride HCl in pharmaceutical formulation. e-J Chem 7:S49–54
   Web of Science ®Google Scholar
• Gupta S, Kapoor V, Kapoor B. (2004). Itopride: a novel prokinetic agent. Drug Rev 6:106–8
   Google Scholar
• Ichikawa M, Kato T, Kawahara M, et al. (1991). A new multiple-unit oral floating dosage system. II. In vivo evaluation of floating and sustained-release characteristics with p-aminobenzoic acid and isosorbide dinitrate as model drugs. J Pharm Sci 80:1153–6
   PubMed Web of Science ®Google Scholar
• Jain SK, Aggarwal GP, Jain NK. (2006). Evaluation of porous carrier-based floating orlistat microspheres for gastric delivery. AAPS PharmSciTech 7:E54–E62
   PubMed Web of Science ®Google Scholar
• Kapil R, Dhawan S, Beg S, Singh B. (2013). Buccoadhesive films for once-a-day administration of rivastigmine: systematic formulation development and pharmacokinetic evaluation. Drug Dev Ind Pharm 39:466–80
   PubMed Web of Science ®Google Scholar
• Kapil R, Dhawan S, Singh B, et al. (2012). Systematic formulation development of once-a-day gastroretentive controlled release tablets of rivastigmine using optimized polymer blends. J Drug Del Sci Tech 22:511–21
   Web of Science ®Google Scholar
• Kawashima Y, Niwa T, Takeuchi H, et al. (1991). Prepration of multiple-unit hollow microspheres (microballoons) with acrylic resin containing traniplast and their drug release characteristics (in vitro) and floating behaviour (in vivo). J Contr Rel 16:279–90
   Web of Science ®Google Scholar
• Korsmeyer RW, Gurny R, Doelker EM, et al. (1983). Mechanism of solute release from porous hydrophilic polymers. Int J Pharm 15:25–35
   Web of Science ®Google Scholar
• Kotreka UK, Adeyeye MC. (2011). Gastroretentive floating drug-delivery systems: a critical review. Crit Rev Ther Drug Carrier Syst 28:47–99
   PubMed Web of Science ®Google Scholar
• Lee J, Park TG, Choi H. (2000). Effect of formulation and processing variables on the characteristics of microspheres for water-soluble drugs prepared by w/o/o double emulsion solvent diffusion method. Int J Pharm 196:75–83
   PubMed Web of Science ®Google Scholar
• Lionberger RA, Lee SL, Lee L, et al. (2008). Quality by design: concepts for ANDAs. AAPS J 10:268–76
   PubMed Web of Science ®Google Scholar
• Murphy CS, Pillay V, Choonara YE, du Toit LC. (2009). Gastroretentive drug delivery systems: current developments in novel system design and evaluation. Curr Drug Deliv 6:451–60
   PubMedGoogle Scholar
• Obeidat WM, Price JC. (2006). Preparation and evaluation of Eudragit S 100 microspheres as pH-sensitive release preparations for piroxicam and theophylline using the emulsion-solvent evaporation method. J Microencapsul 23:195–202
   PubMed Web of Science ®Google Scholar
• Pahwa R, Singh M, Kumar V, Kohli K. (2012). Recent advances and patent perspectives in gastroretentive technology. Recent Pat Drug Deliv Formul 6:278–90
   PubMedGoogle Scholar
• Pawar VK, Kansal S, Garg G, et al. (2010). Gastroretentive dosage forms: a review with special emphasis on floating drug delivery systems. Drug 18:97–110
   Google Scholar
• Phutane P, Shidhaye S, Lotlikar V, et al. (2010). In vitro evaluation of novel sustained release microspheres of glipizide prepared by the emulsion solvent diffusion-evaporation method. J Young Pharm 2:35–41
   PubMedGoogle Scholar
• Sato Y, Kawashima Y, Takeuchi H, Yamamoto H. (2004a). In vitro and in vivo evaluation of riboflavin-containing microballoons for a floating controlled drug delivery system in healthy humans. Int J Pharm 275:97–107
   PubMed Web of Science ®Google Scholar
• Sato Y, Kawashima Y, Takeuchi H, Yamamoto H. (2004b). In vitro evaluation of floating and drug releasing behaviors of hollow microspheres (microballoons) prepared by the emulsion solvent diffusion method. Eur J Pharm Biopharm 57:235–43
   PubMed Web of Science ®Google Scholar
• Sato Y, Kawashima Y, Takeuchi H, et al. (2004c). Pharmacoscintigraphic evaluation of riboflavin-containing microballoons for a floating controlled drug delivery system in healthy humans. J Contr Rel 98:75–85
   PubMed Web of Science ®Google Scholar
• Singh B, Ahuja N. (2002). Development of controlled-release buccoadhesive hydrophilic matrices of diltiazem hydrochloride: optimization of bioadhesion, dissolution, and diffusion parameters. Drug Dev Ind Pharm 28:431–42
   PubMed Web of Science ®Google Scholar
• Singh B, Chakkal SK, Ahuja N. (2006). Formulation and optimization of controlled release mucoadhesive tablets of atenolol using response surface methodology. AAPS PharmSciTech 7:E19–E28
   PubMed Web of Science ®Google Scholar
• Singh B, Dahiya M, Saharan V, Ahuja N. (2005a). Optimizing drug delivery systems using systematic “design of experiments”. Part II: retrospect and prospects. Crit Rev Ther Drug Carrier Syst 22:215–94
   PubMed Web of Science ®Google Scholar
• Singh B, Garg B, Chaturvedi SC, et al. (2012). Formulation development of gastroretentive tablets of lamivudine using the floating-bioadhesive potential of optimized polymer blends. J Pharm Pharmacol 64:654–69
   PubMed Web of Science ®Google Scholar
• Singh B, Kapil R, Nandi M, Ahuja N. (2011). Developing oral drug delivery systems using formulation by design: vital precepts, retrospect and prospects. Expert Opin Drug Deliv 8:1341–60
   PubMed Web of Science ®Google Scholar
• Singh B, Kaur T, Singh S. (1997). Correction of raw dissolution data for loss of drug during sampling. Indian J Pharm Sci 59:196–9
   Google Scholar
• Singh B, Kumar R, Ahuja N. (2005b). Optimizing drug delivery systems using systematic “design of experiments.” Part I: fundamental aspects. Crit Rev Ther Drug Carrier Syst 22:27–105
   PubMed Web of Science ®Google Scholar
• Singh B, Pahuja S, Kapil R, Ahuja N. (2009). Formulation development of oral controlled release tablets of hydralazine: optimization of drug release and bioadhesive characteristics. Acta Pharm 59:1–13
   PubMed Web of Science ®Google Scholar
• Singh B, Rani A, Garg B, et al. (2010). Formulation optimization of hydrodynamically balanced oral controlled release bioadhesive tablets of tramadol hydrochloride. Sci Pharm 78:303–23
   PubMedGoogle Scholar
• Singh B, Raza K, Beg S. (2013). Developing “optimized” drug products employing “Designed” experiments. Chem Ind Digest 6:70–76
   Google Scholar
• Singh B, Singh S. (1998). A comprehensive computer program for study of drug release kinetics from compressed matrices. Indian J Pharm Sci 60:313–16
   Google Scholar
• Vora C, Patadia R, Mittal K, Mashru R. (2013). Risk based approach for design and optimization of stomach specific delivery of rifampicin. Int J Pharm 455:169–81
   PubMed Web of Science ®Google Scholar